Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine

Darius A. Rastegar; Sarah Sharfstein Kawasaki; Van L. King; Elizabeth E. Harris; Robert K. Brooner

doi:10.3109/10826084.2016.1155608

Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine

Darius A. Rastegar, Sarah Sharfstein Kawasaki, Van L. King, Elizabeth E. Harris, Robert K. Brooner

Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p

Original language	English (US)
Pages (from-to)	803-811
Number of pages	9
Journal	Substance Use and Misuse
Volume	51
Issue number	7
DOIs	https://doi.org/10.3109/10826084.2016.1155608
State	Published - Jun 6 2016

Keywords

buprenorphine
Crime
methadone
opioid agonist treatment
opioid-related disorders

ASJC Scopus subject areas

Psychiatry and Mental health
Public Health, Environmental and Occupational Health
Health(social science)
Medicine (miscellaneous)

Access to Document

10.3109/10826084.2016.1155608

Fingerprint Dive into the research topics of 'Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine'. Together they form a unique fingerprint.

Cite this

Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment : A Comparison of Methadone Maintenance and Office-based Buprenorphine. / Rastegar, Darius A.; Sharfstein Kawasaki, Sarah; King, Van L.; Harris, Elizabeth E.; Brooner, Robert K.

In: Substance Use and Misuse, Vol. 51, No. 7, 06.06.2016, p. 803-811.

Research output: Contribution to journal › Article › peer-review

@article{9a487eaf70c647a88316fb556e7a6f0c,

title = "Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine",

abstract = "Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p ",

keywords = "buprenorphine, Crime, methadone, opioid agonist treatment, opioid-related disorders",

author = "Rastegar, {Darius A.} and {Sharfstein Kawasaki}, Sarah and King, {Van L.} and Harris, {Elizabeth E.} and Brooner, {Robert K.}",

year = "2016",

month = jun,

day = "6",

doi = "10.3109/10826084.2016.1155608",

language = "English (US)",

volume = "51",

pages = "803--811",

journal = "Substance Use and Misuse",

issn = "1082-6084",

publisher = "Informa Healthcare",

number = "7",

}

TY - JOUR

T1 - Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment

T2 - A Comparison of Methadone Maintenance and Office-based Buprenorphine

AU - Rastegar, Darius A.

AU - Sharfstein Kawasaki, Sarah

AU - King, Van L.

AU - Harris, Elizabeth E.

AU - Brooner, Robert K.

PY - 2016/6/6

Y1 - 2016/6/6

N2 - Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p

AB - Background: Entry into methadone maintenance is associated with a reduction in criminal activity; less is known about the effects of office-based buprenorphine. Objective: To compare criminal charges before and after enrollment in methadone maintenance or office-based buprenorphine. Methods: Subjects were opioid-dependent adults who initiated either methadone maintenance (n = 252) or office-based buprenorphine (n = 252) between 2003 and 2007. Medical records were reviewed to gather demographic data and a state-maintained web-based database to collect data on criminal charges. Overall charges and drug charges in the 2 years prior to and after treatment enrollment were compared. Multivariable analysis was used to examine risk factors for charges after treatment enrollment. Results: In the 2 years after enrolling in treatment, subjects receiving methadone had a significant decline in the proportion of subjects with any charges (49.6% vs. 32.5%, p

KW - buprenorphine

KW - Crime

KW - methadone

KW - opioid agonist treatment

KW - opioid-related disorders

UR - http://www.scopus.com/inward/record.url?scp=84964528875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964528875&partnerID=8YFLogxK

U2 - 10.3109/10826084.2016.1155608

DO - 10.3109/10826084.2016.1155608

M3 - Article

C2 - 27097276

AN - SCOPUS:84964528875

VL - 51

SP - 803

EP - 811

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 7

ER -

Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this